Clinical Trials Directory

Trials / Completed

CompletedNCT02416947

Soluble Corn Fiber Effect on Bone Resorption in Post Menopausal Women

The Effect of Soluble Corn Fiber (SCF) on Bone Resorption in Post-Menopausal Women Using 41Calcium Technology

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
14 (actual)
Sponsor
Purdue University · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

This study is designed to study the dose response effect of continuous Soluble Corn Fiber (SCF) intake over a 50 day period on bone resorption in healthy post menopausal women using the 41Calcium methodology. To further understand the dose response effect of SCF bone biomarkers will be studied. Our hypothesis is that soluble corn fiber will reduce bone resorption in a dose dependent manner in comparison to placebo when estimated by urinary 41Calcium excretion as well as bone biomarkers of resorption.

Detailed description

Subjects will be dosed with 41Calcium , a long-lived radio isotope, which will become deposited in the skeleton after about 100 days. During this time subjects will collect 24 h urine monthly to monitor the decrease in 41Calcium urinary excretion. Subsequently, the baseline level of 41Calcium urinary excretion will be evaluated over a 50 day baseline period with 24 h urine collections every 10 days. Participants will then be randomized to one of three doses of soluble corn fiber (0,10,20 g/d) to be consumed in two equivalent doses per day for 50 days. Women will collect 24 h urine every 10 days. Each 50 day period will be followed by a 50 day washout period during which the subjects will continue to collect urine every 10 days.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT0 g SCF0 grams of SCF will be administered daily in two equal doses in the form of a muffin and a drink.
DIETARY_SUPPLEMENT10g SCF10 grams of SCF will be administered daily in two equal doses in the form of a muffin and a drink.
DIETARY_SUPPLEMENT20g SCF20 grams of SCF will be administered daily in two equal doses in the form of a muffin and a drink.

Timeline

Start date
2012-03-01
Primary completion
2015-01-01
Completion
2015-01-01
First posted
2015-04-15
Last updated
2015-04-15

Source: ClinicalTrials.gov record NCT02416947. Inclusion in this directory is not an endorsement.